Treatment of idiopathic generalized epilepsy - A review of the evidence

Expert Opinion on Pharmacotherapy

Volumn 13, Issue 9, 2012, Pages 1283-1298

  Beydoun, Ahmad ^a   D'Souza, Joseph ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UCB PHARMA   (Belgium)

Author keywords

AED; Clinical trials; Epilepsy; Idiopathic generalized epilepsy; Treatment

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; HARKOSERIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; TIAGABINE; TOPIRAMATE; VALPROATE MAGNESIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ABSENCE; ADD ON THERAPY; ANTICONVULSANT THERAPY; ATONIC SEIZURE; CHILDHOOD ABSENCE EPILEPSY; CLONIC SEIZURE; DISEASE EXACERBATION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; EVIDENCE BASED MEDICINE; FATIGUE; GENERALIZED EPILEPSY; HUMAN; IRRITABILITY; JUVENILE ABSENCE EPILEPSY; LOW DRUG DOSE; MEMORY DISORDER; META ANALYSIS; MONOTHERAPY; MOOD SWING; MYOCLONUS EPILEPSY; NAUSEA; NERVOUSNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; RHINOPHARYNGITIS; RISK REDUCTION; SEIZURE THRESHOLD; SIDE EFFECT; SOMNOLENCE; SPIKE WAVE; SYSTEMATIC REVIEW; TONIC CLONIC SEIZURE; TONIC SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WEIGHT REDUCTION;

ANTICONVULSANTS; BRAIN; BRAIN WAVES; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY, GENERALIZED; EVIDENCE-BASED MEDICINE; HUMANS; TREATMENT OUTCOME;

EID: 84861417664     PISSN: 14656566     EISSN: 17447666     Source Type: Journal    
DOI: 10.1517/14656566.2012.685162     Document Type: Review

References (71)

1. Engel J Jr. Seizures and Epilepsy, Contemporary Neurology Series. Volume 31 FA Davis; Philadelphia, PA: 1989
2. Mattson RH. Overview: idiopathic generalized epilepsies. Epilepsia 2003;44(Suppl 2):2-6
3. Fisher RS, van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia 2005;46:470-2
4. Fisher RS, Leppik I. Debate: when does a seizure imply epilepsy? Epilepsia 2008;49(Suppl 9):7-12
5. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia 1981;22:489-501
6. Engel J Jr. Classification of epileptic disorders. Epilepsia 2001;42:316
7. Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-99
8. Berg AT, Berkovic SF, Brodie MJ, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005 - 2009. Epilepsia 2010;51:676-85
9. Panayiotopoulos CP. The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician's critical view and contribution. Epilepsia 2011;52:2155-60
10. Panayiotopoulos CP. Idiopathic generalized epilepsies: a review and modern approach. Epilepsia 2005;46(Suppl 9):1-6
11. Koutroumanidis M, Smith S. Use and abuse of EEG in the diagnosis of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):96-107
12. Villarreal HJ, Wilder BJ, Willmore LJ, et al. Effect of valproic acid on spike and wave discharges in patients with absence seizures. Neurology 1978;28:886
13. Callaghan N, O'Hare J, O'Driscoll D, et al. Comparative study of ethosuximide and sodium valproate in the treatment of typical absence seizures (Petit Mal). Dev Med Child Neurol 1982;24:830-6
14. Sato S, White BG, Penry JK, et al. Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology 1982;32:157-63
15. Hitiris N, Brodie MJ. Evidence-based treatment of idiopathic generalized epilepsies with older antiepileptic drugs. Epilepsia 2005;46(Suppl 9):149-53
16. Zimmerman FT, Burgemeister BB. A new drug for petit mal epilepsy. Neurology 1958;8:769-75
17. Heathfield KW, Jewesbury EC. Treatment of petit mal with ethosuximide. Br Med J 1961;2:565-7
18. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia 1982;23:693-720
19. Dulac O, Steru D, Rey E, et al. Sodium valproate (Na VPa) monotherapy in childhood epilepsy. Arch Fr Pediatr 1982;39:347-52
20. Bourgeois B, Beaumanoir A, Blajev B, et al. Monotherapy with valproate in primary generalized epilepsies. Epilepsia 1987;28(Suppl 2):S8-11
21. Gelisse P, Genton P, Kuate C, et al. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies. Epilepsia 2004;45:1282-6
22. Benbadis SR, Tatum WOT, Gieron M. Idiopathic generalized epilepsy and choice of antiepileptic drugs. Neurology 2003;61:1793-5
23. Jallon P, Latour P. Epidemiology of idiopathic generalized epilepsies. Epilepsia 2005;46(Suppl 9):10-14
24. Manford M, Hart YM, Sander JW, et al. The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol 1992;49:801-8
25. Gastaut H, Gastaut JL, Goncalves e Silva GE, et al. Relative frequency of different types of epilepsy: a study employing the classification of the International League Against Epilepsy. Epilepsia 1975;16:457-61
26. Panayiotopoulos CP. A Clinical Guide to Epileptic Syndromes and their Treatment. 2nd edition. Springer; London: 2007
27. Sadleir LG, Scheffer IE, Smith S, et al. EEG features of absence seizures in idiopathic generalized epilepsy: impact of syndrome, age, and state. Epilepsia 2009;50:1572-8
28. Nordli DR Jr. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):48-56
29. Commission on Pediatric Epilepsy of the International League Against Epilepsy. Myoclonus and epilepsy in childhood. Epilepsia 1997;38:1251-4
30. Panayiotopoulos CP. Syndromes of idiopathic generalized epilepsies not recognized by the International League Against Epilepsy. Epilepsia 2005;46(Suppl 9):57-66
31. Guerrini R, Parmeggiani L, Marini C, et al. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with linkage to chromosome 2p11.1-q12.2. Adv Neurol 2005;95:273-9
32. Striano P, Zara F, Striano S. Autosomal dominant cortical tremor, myoclonus and epilepsy: many syndromes, one phenotype. Acta Neurol Scand 2005;111:211-17
33. Callenbach PM, Geerts AT, Arts WF, et al. Familial occurrence of epilepsy in children with newly diagnosed multiple seizures: dutch Study of Epilepsy in Childhood. Epilepsia 1998;39:331-6
34. Berg AT, Levy SR, Testa FM, et al. Classification of childhood epilepsy syndromes in newly diagnosed epilepsy: interrater agreement and reasons for disagreement. Epilepsia 1999;40:439-44
35. Adie WJ. Pyknolepsy: a form of epilepsy in children, with a good prognosis. Proc R Soc Med 1924;17:19-25
36. Loiseau J, Panayiotopoulos P. Childhood absence epilepsy [Internet]. 2000. Available from: http://www.ilae-epilepsy. org/ctf/childhood-absence.html [last accessed June 2011]
37. Panayiotopoulos CP, Obeid T, Waheed G. Differentiation of typical absence seizures in epileptic syndromes. A video EEG study of 224 seizures in 20 patients. Brain 1989;112:1039-56
38. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006;47:10941-20
39. Beydoun A, Milling CJ. Active-control comparative equivalency monotherapy trials in epilepsy: are they scientifically valid? Epilepsy Behav 2001;2:187-92
40. Glauser TA, Cnaan A, Shinnar S, et al. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med 2010;362:790-9
41. Arroyo S, Dodson WE, Privitera MD, et al. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005;112:214-22
42. Brodie MJ, Richens A, Yuen AW; UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9
43. Frank LM, Enlow T, Holmes GL, et al. Lamictal (lamotrigine) monotherapy for typical absence seizures in children. Epilepsia 1999;40:973-9
44. Steinhoff BJ, Ueberall MA, Siemes H, et al. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults. Seizure 2005;14:597-605
45. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007;369:1016-26
46. Fattore C, Boniver C, Capovilla G, et al. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. Epilepsia 2011;52:802-9
47. Canger R, Guidolin L. Clinical efficacy and tolerability of magnesium valproate as monotherapy in patients with generalised or partial epilepsy: a nonblinded study of 320 patients. Clin Drug Investig 2000;20:215-21
48. Genton P, Gelisse P, Thomas P, et al. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy? Neurology 2000;55:1106-9
49. Brodie MJ, Chadwick DW, Anhut H, et al. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 2002;43:993-1000
50. Nicolson A, Appleton RE, Chadwick DW, et al. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry 2004;75:75-9
51. Guerrini R, Carpay J, Groselj J, et al. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Seizure 2005;14:371-80
52. Mohanraj R, Brodie MJ. Pharmacological outcomes in newly diagnosed epilepsy. Epilepsy Behav 2005;6:382-7
53. Wilfong A, Schultz R. Zonisamide for absence seizures. Epilepsy Res 2005;64:31-4
54. Bauer J, Buchmuller L, Reuber M, et al. Which patients become seizure free with antiepileptic drugs? An observational study in 821 patients with epilepsy. Acta Neurol Scand 2008;117:55-9
55. Nejad S, Nikpour M, Rahim F, et al. A randomized open-label comparison of lamotrigine and valproate in patients with juvenile myoclonic epilepsy. Int J Pharmacol 2009;5:313-18
56. Lombroso CT, Forxythe I. A long-term follow-up of acetazolamide (diamox) in the treatment of epilepsy. Epilepsia 1960;1:493-500
57. Resor SR Jr, Resor LD. Chronic acetazolamide monotherapy in the treatment of juvenile myoclonic epilepsy. Neurology 1990;40:1677-81
58. Atakli D, Sozuer D, Atay T, et al. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 1998;7:63-6
59. Holland KD, Monahan S, Morita D, et al. Valproate in children with newly diagnosed idiopathic generalized epilepsy. Acta Neurol Scand 2010;121:149-53
60. Biton V, Montouris GD, Ritter F, et al. A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology 1999;52:1330-7
61. Biton V, Sackellares JC, Vuong A, et al. Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures. Neurology 2005;65:1737-43
62. Trevathan E, Kerls SP, Hammer AE, et al. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures. Pediatrics 2006;118:e371-8
63. Biton V, Di Memmo J, Shukla R, et al. Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study. Epilepsy Behav 2010;19:352-8
64. Berkovic SF, Knowlton RC, Leroy RF, et al. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 2007;69:1751-60
65. Noachtar S, Andermann E, Meyvisch P, et al. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures. Neurology 2008;70:607-16
66. Beran RG, Berkovic SF, Dunagan FM, et al. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy. Epilepsia 1998;39:1329-33
67. Golla FL, Hodge RS. Control of petit mal by acetazolamide. J Ment Sci 1957;103:214-17
68. Mikkelsen B, Birket-Smith E, Bradt S, et al. Clonazepam in the treatment of epilepsy. A controlled clinical trial in simple absences, bilateral massive epileptic myoclonus, and atonic seizures. Arch Neurol 1976;33:322-5
69. Posner EB, Mohamed K, Marson AG. Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2005;4:CD003032
70. Adab N, Kini U, Vinten J, et al. The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 2004;75:1575-83
71. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006;77:193-8